US Stocks
/
Climb Bio, Inc. Share Price
Climb Bio, Inc. Share Price

Climb Bio, Inc. Share Price

NASDAQ: CLYM | Small Cap
$10.86
+$0.14 (1.35%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Climb Bio, Inc. Stock Performance

Open
$10.43
Prev. Close
$10.71
Circuit Range
N/A
Day Range
$10.27 - $10.98
Year Range
$1.64 - $18.32
Volume
1,13,244
Average Traded
$10.59

Climb Bio, Inc. Share Price Today

As of 9 October 2026, Climb Bio, Inc.'s share price is $10.86. The stock opened at $10.43, compared to its previous close of $10.71. During today's trading session, Climb Bio, Inc.'s share price traded between $10.27 and $10.98, with an average price of $10.63. Over the past 52 weeks, the stock has recorded a high of $18.32 and a low of $1.64. In terms of performance, Climb Bio, Inc.'s share price has risen by 22.44% over the last six months and is up 432.35% on a year-on-year basis.

Climb Bio, Inc. Share Price Chart

$10.27$10.98
L
Show Current Price
H

Climb Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$736.44M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.00
Revenue (TTM)
$0.00
Return On Equity (TTM)
-24.06%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-4.73%

Climb Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.89-$17.52-$13.72-$13.50
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-35.92%21.69%1.60%

Climb Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$73.90-$59.85
Net Profit MarginN/AN/A
Income ChangeN/A19.01%

About Climb Bio, Inc.

Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.

Climb Bio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$11.38
$10.88
-5.52%
Sep 2026
$13.29
$11.51
-23.60%
Aug 2026
$11.67
$15.06
+26.54%
Jul 2026
$12.98
$11.90
-8.77%
Jun 2026
$10.94
$13.05
+19.18%
May 2026
$8.61
$10.95
+23.45%
Apr 2026
$7.10
$8.87
+29.49%
Mar 2026
$6.79
$6.85
-4.60%
Feb 2026
$4.50
$7.18
+60.63%
Jan 2026
$4.10
$4.47
+11.75%
Dec 2025
$1.86
$4.00
+112.77%
Nov 2025
$2.06
$1.88
-7.84%

CLYM Share Price FAQs

What is Climb Bio, Inc. share price today?

chevron-up
Climb Bio, Inc. share price today is $10.86 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Climb Bio, Inc. stock?

chevron-up
The 52 week high of Climb Bio, Inc. stock is $18.32, while the 52 week low is $1.64 as of 9 Oct '26.

What is CLYM's market capitalisation today?

chevron-up
CLYM market capitalisation is $736.44M as of October 9, 2026, at 6:10 pm IST.

What is CLYM's net income for the last quarter?

chevron-up
CLYM's net income for the last quarter is -13.50B USD.

What is the 5 year returns of CLYM?

chevron-up
The 5 year returns of CLYM is -38.01% as on 9 Oct '26.

What is the high & low stock price of CLYM today?

chevron-up
CLYM stock price hit a high of $10.98 and low of $10.27 as of 9 Oct '26.

Can I buy CLYM shares in India?

chevron-up
Yes. You can buy CLYM in India by opening an international trading account.